Article ID Journal Published Year Pages File Type
8528677 Current Opinion in Pharmacology 2018 9 Pages PDF
Abstract
Statins and ACE inhibitors have been shown to enhance endogenous nitric oxide and improve intermittent claudication symptoms. Studies using l-arginine have produced differing results, for reasons for yet fully understood. A greater understanding of the nitric oxide pathway, and its enzymatic control, has generated more potential therapeutic targets to alter NO levels.
Related Topics
Life Sciences Neuroscience Cellular and Molecular Neuroscience
Authors
, , , , , , ,